Delivery Order SPE2DB20D2014-SPE2DB25FB04Y
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$21K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,363.12 delivery order contract is for the supply of CELLCEPT 500 MG TABLET 100S, a specialty medication. The contract has a firm fixed price and a completion date of March 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,494.11, is for the delivery of CELLCEPT 500 MG TABLET 100S. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,069.14 firm fixed-price delivery order is for the supply of 4,566,810,176 units of the drug CellCept 500 mg tablets. The contract has an ultimate completion date of December 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of CellCept 500 mg tablets. The contract has a ceiling value of $16,893.64 and is a firm fixed-price delivery order with a completion date of November 20, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $2,325.88, is for the delivery of CellCept 500 mg tablets in quantities of 100. This is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. The contract has no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several significant Indefinite...
This federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products, specifically CellCept 500 mg tablets. The $64,962.67 firm fixed-price contract was awarded on January 18, 2024, with an ultimate completion date of January 19, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract, valued at $25,351.33, is for the delivery of CELLCEPT 500 MG TABLET 100S, a pharmaceutical product, with a period of performance through August 6, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of CellCept 500 mg tablets. The contract is valued at $13,867.86 and has an ultimate completion date of December 30, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a wide range of medical products and supplies. The contract, valued at up to $40,957.11, is a Delivery Order with a Firm Fixed Price pricing type. The award does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office Division, will supply the DLA with products such as the drug CellCept...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDVZ9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567058572 CELLCEPT 500 MG TABLET 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has a ceiling value of $23,322.56. The period of performance runs through January 28, 2025. The contract does not have a set-aside designation,...